Skip to main content

Articles

Page 2 of 17

  1. Obstructive shock is extremely rare in clinical practice and is caused by acute blood flow obstruction in the central vessels of either the systemic or pulmonary circulation. Utilizing inferior vena cava filte...

    Authors: ShuTing Gao, YunFei Chen, YaTing Huang, YiPing Dang and YiQing Li
    Citation: Thrombosis Journal 2024 22:7
    Content type: Case Report Published on:

  3. The prothrombotic state is a common abnormality in patients with coronavirus disease 2019 (COVID-19). However, there is controversy over the use of anticoagulants, especially oral anticoagulants (OAC) due to l...

    Authors: Xing Wang, Wuqian Chen, Jiulin Guo, Xingyu Qiu, Chao You and Lu Ma
    Citation: Thrombosis Journal 2024 22:5
    Content type: Research Published on:

  4. Primary pulmonary artery sarcoma (PAS) is an extremely rare malignant tumor with a poor prognosis. The clinical manifestations of PAS are diverse, including dyspnea, chest pain, cough, and hemoptysis. The poor...

    Authors: Zhiyue Liu, Lili Fan, Shichu Liang, Zhong Wu and He Huang
    Citation: Thrombosis Journal 2024 22:4
    Content type: Case Report Published on:

  5. Deep venous thrombosis (DVT) is the common clinical cardiovascular disease, and easily develops into post-thrombotic syndrome (PTS). The study aimed to examine the clinical value of long non-coding RNA NORAD gene...

    Authors: Kun Zhou, Na Li, Jia Qi, Pingping Tu, Yan Yang and Hui Duan
    Citation: Thrombosis Journal 2024 22:3
    Content type: Research Published on:

  6. The benefit-risk profile of direct oral anticoagulants (DOAC) therapy in patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF) has not been well established yet. This study aimed to eval...

    Authors: Si-qi Lyu, Jun Zhu, Juan Wang, Shuang Wu, Han Zhang, Xing-hui Shao and Yan-min Yang
    Citation: Thrombosis Journal 2024 22:2
    Content type: Review Published on:

  7. Hereditary predisposition play an important role in thrombosis, especially in younger patients. Here we studied a young patient who experienced three different episodes of severe thromboses, some of which were...

    Authors: Xuqian Wei, Houliang Zhang, Weibin Chen, Jian Zhang and Jing Dai
    Citation: Thrombosis Journal 2024 22:1
    Content type: Research Published on:

  8. Optimising periprocedural management of direct oral anticoagulation in patients with atrial fibrillation on chronic treatment undergoing major surgeries is an important aspect of balancing the risk of surgery-...

    Authors: Christian von Heymann, Martin Unverdorben, Paolo Colonna, Amparo Santamaria, Manish Saxena, Thomas Vanassche, Sabine Köhler, Amanda P. Borrow, James Jin and Cathy Chen
    Citation: Thrombosis Journal 2023 21:124
    Content type: Research Published on:

  9. Congenital antithrombin deficiency is an autosomal dominant disease that results in deep venous thrombosis and pulmonary embolism, which is mainly caused by mutations in the antithrombin gene (SERPINC1). Since SE...

    Authors: Yuwen Huang, Yinling Wang, Xiaoli Wang, Jue Liu, Bing Luo and Yuanmei Gao
    Citation: Thrombosis Journal 2023 21:123
    Content type: Case Report Published on:

  10. Von Willebrand factor (VWF) and factor VIII (FVIII) complex play a pivotal role in hemostasis. A deficiency or defect of VWF causes von Willebrand disease (VWD). Recombinant (r)VWF product has proved to be eff...

    Authors: Hiroaki Yaoi, Yasuaki Shida, Kenichi Ogiwara and Keiji Nogami
    Citation: Thrombosis Journal 2023 21:122
    Content type: Research Published on:

  12. Available evidence to identify factors independently associated with failed thromboprophylaxis (FT) in medical patients is insufficient. The present study seeks to evaluate in hospitalized patients, which clin...

    Authors: Santiago Grillo Pérez, Paula Ruiz-Talero and Oscar Mauricio Muñoz Velandia
    Citation: Thrombosis Journal 2023 21:120
    Content type: Research Published on:

  13. Thrombotic Microangiopathy (TMA) is a syndrome characterized by the presence of anemia, thrombocytopenia and organ damage and has multiple etiologies. The primary aim is to develop an algorithm to classify TMA...

    Authors: Vanessa Vilani Addad, Lilian Monteiro Pereira Palma, Maria Helena Vaisbich, Abner Mácola Pacheco Barbosa, Naila Camila da Rocha, Marilia Mastrocolla de Almeida Cardoso, Juliana Tereza Coneglian de Almeida, Monica AP de Paula de Sordi, Juliana Machado-Rugolo, Lucas Frederico Arantes and Luis Gustavo Modelli de Andrade
    Citation: Thrombosis Journal 2023 21:119
    Content type: Research Published on:

  14. There are limited data about the clinical benefits and harm of direct oral anticoagulants (DOACs) in stroke prevention in patients with atrial fibrillation (AF) complicated with anemia or thrombocytopenia.

    Authors: Wenlin Xu, Jiana Chen, Shuyi Wu, Nianxu Huang, Xia Chen, Wang Zhang, Wei Hu, Jun Su, Hengfen Dai, Ping Gu, Xiaohong Huang, Xiaoming Du, Ruijuan Li, Qiaowei Zheng, Xiangsheng Lin, Yanxia Zhang…
    Citation: Thrombosis Journal 2023 21:118
    Content type: Research Published on:

  15. Mixed phenotype acute leukaemia (MPAL) is associated with worse overall survival, compared with other acute leukaemias in adults. Lack of clear treatment guidelines makes the therapy challenging. ALL-like indu...

    Authors: Wojciech Lizurej, Łukasz Mazurkiewicz, Michał Kowalski, Sylwia Szydłowska, Michał Wyrzykowski and Krzysztof Lewandowski
    Citation: Thrombosis Journal 2023 21:117
    Content type: Case Report Published on:

  16. Cerebral venous sinus thrombosis (CVST) can cause sinus obstruction and stenosis, with potentially fatal consequences. High-resolution magnetic resonance imaging (HRMRI) can diagnose CVST qualitatively, althou...

    Authors: Yu-zhou Chang, Hao-Yu Zhu, Yu-Qi Song, Xu Tong, Xiao-Qing Li, Yi-Long Wang, Ke-Hui Dong, Chu-Han Jiang, Yu-Peng Zhang and Da-Peng Mo
    Citation: Thrombosis Journal 2023 21:116
    Content type: Research Published on:

  17. Alpha-thalassemia (α-thalassemia) is one of the most common monogenic diseases in Saudi Arabia and is associated with significant morbidity. Premarital testing programs in Saudi Arabia reduce the burden of hem...

    Authors: Hayaa M. Alhuthali, Eman F. Ataya, Alaa Alsalmi, Triq E Elmissbah, Khalaf F Alsharif, Hind A. Alzahrani, Ahad Amer Alsaiari, Mamdouh Allahyani, Amal F. Gharib, Husam Qanash, Heba M. Elmasry and Doha Elsayed Hassanein
    Citation: Thrombosis Journal 2023 21:115
    Content type: Research Published on:

  19. Systemic lupus erythematosus (SLE) patients have an increased risk of cardiovascular disease and thrombotic events, and the presence of antiphospholipid antibodies further raises the risk of these complication...

    Authors: Chiara Schiavi, Luca Marri and Simone Negrini
    Citation: Thrombosis Journal 2023 21:113
    Content type: Case Report Published on:

  20. Disseminated intravascular coagulation (DIC) is a common and critical complication in sepsis. Antithrombin activity, which is considered a biomarker for disease severity, was measured in septic DIC treated wit...

    Authors: Toshiaki Iba, Tomoki Tanigawa, Hideo Wada and Jerrold H. Levy
    Citation: Thrombosis Journal 2023 21:112
    Content type: Research Published on:

  21. Venous thromboembolic events (VTE) are a significant cause of morbidity and mortality following traumatic injury. We examined demographic characteristics, chemoprophylaxis, and outcomes of VTE patients with bl...

    Authors: Camille Lineberry, Dimitri Alexis, Ambika Mukhi, Kevin Duh, Mathew Tharakan, James A. Vosswinkel and Randeep S. Jawa
    Citation: Thrombosis Journal 2023 21:111
    Content type: Research Published on:

  22. Current clinical practice guidelines lack explicit guidance on the indications and appropriate timing of venous ultrasound (US) in lower extremity deep vein thrombosis (DVT) follow-up. Moreover, abnormal findi...

    Authors: Farooq Akram, Bingwen Eugene Fan, Chuen Wen Tan, Wey Chyi Teoh, Paolo Prandoni and Eng Soo Yap
    Citation: Thrombosis Journal 2023 21:110
    Content type: Review Published on:

  23. Previous cohort studies have shown that exogenous sex hormone use, such as testosterone replacement therapy and oestrogen-containing contraceptives, can increase the risk of venous thromboembolism (VTE). Howev...

    Authors: Shuping Wang, Yongxiang Wang, Ming Bai, Yu Peng, Dan Zhou, Peng Lei, Binpeng Zhou, Piyi Zhang and Zheng Zhang
    Citation: Thrombosis Journal 2023 21:109
    Content type: Research Published on:

  24. Hemophilia A (HEMA) is an X-linked bleeding disorder caused by reduced/absent coagulation factor VIII expression, as a result of pathogenic variants in the F8 gene. Preimplantation prevention of HEMA should ideal...

    Authors: Minh Tam Nguyen, Thanh Tung Nguyen, Duy Bac Nguyen, Thi Mai Nguyen, Kim Ngan Nguyen, Van Nhat Minh Ngo, Van Dieu Nguyen, Ngoc Anh Tran, Mulias Lian, Arnold S. C. Tan, Samuel S. Chong and Tien Truong Dang
    Citation: Thrombosis Journal 2023 21:108
    Content type: Research Published on:

  25. Immune thrombocytopenia (ITP) is an autoimmune hemorrhagic disease characterized by increased platelet destruction and impaired thrombopoiesis. The changes in platelet indices depend on the morphology and volu...

    Authors: Pengcheng Xu, Shouqing Han, Ming Hou, Yajing Zhao and Miao Xu
    Citation: Thrombosis Journal 2023 21:107
    Content type: Research Published on:

  26. Deep venous thrombosis (DVT) prediction after total hip and knee arthroplasty remains challenging. Early diagnosis and treatment of DVT are crucial. This research aimed to develop a nomogram for early DVT pred...

    Authors: Zhencan Lin, Hao Sun, Deng Li, Zhiqing Cai, Zhencheng Huang, Fangzhou Liu, Meiyi Chen, Yimin Wang, Jie Xu and Ruofan Ma
    Citation: Thrombosis Journal 2023 21:106
    Content type: Research Published on:

  27. Individuals with multiple myeloma (MM) receiving immunomodulatory drugs (IMiDs) are at risk of developing venous thromboembolism (VTE), a serious complication. There is no established clinical model for predic...

    Authors: Xiaozhe Li, Xiuli Sun, Baijun Fang, Yun Leng, Fangfang Sun, Yaomei Wang, Qing Wang, Jie Jin, Min Yang, Bing Xu, Zhihong Fang, Lijuan Chen, Zhi Chen, Qimei Yang, Kejie Zhang, Yinhai Ye…
    Citation: Thrombosis Journal 2023 21:105
    Content type: Research Published on:

  28. Fluorogenic thrombin generation (TG) is a global hemostasis assay that provides an overall representation of hemostasis potential. However, the accurate detection of thrombin activity in plasma may be affected...

    Authors: Joseph W. Jackson, Colin Longstaff, Samuel A. Woodle, William C. Chang and Mikhail V. Ovanesov
    Citation: Thrombosis Journal 2023 21:104
    Content type: Research Published on:

  29. R189W and K193del of protein C (PC) were hotspot mutations in Chinese population with venous thromboembolism (VTE), but almost two-thirds of patients with above mutations coexisting with other genetically or a...

    Authors: Lei Li, Jian Li, Xi Wu, Wenman Wu, Qiulan Ding, Baohua Qian and Xuefeng Wang
    Citation: Thrombosis Journal 2023 21:103
    Content type: Research Published on:

  30. Immune thrombocytopenia (ITP) is an autoimmune hemorrhagic disease characterized by low platelet count and bleeding manifestations. However, some patients also suffered from atherosclerosis or even infarction....

    Authors: Shouqing Han, Hui Lu, Yafei Yu, Xinguang Liu, Fangmiao Jing, Liang Wang, Yajing Zhao and Ming Hou
    Citation: Thrombosis Journal 2023 21:102
    Content type: Research Published on:

  31. Patients with critical COVID-19 have a high risk of thromboembolism, but intensified thromboprophylaxis has not been proven beneficial. The activity of low-molecular-weight heparins can be monitored by measuri...

    Authors: Sandra Jonmarker, Jacob Litorell, Felix Alarcon, Kais Al-Abani, Sofia Björkman, Maria Farm, Jonathan Grip, Mårten Söderberg, Jacob Hollenberg, Rebecka Rubenson Wahlin, Thomas Kander, Liivi Rimling, Johan Mårtensson, Eva Joelsson-Alm, Martin Dahlberg and Maria Cronhjort
    Citation: Thrombosis Journal 2023 21:101
    Content type: Research Published on:

  32. In case of heparin-induced thrombocytopenia (HIT), the switch to a non-heparin anticoagulant is mandatory, at a therapeutic dose. Such a treatment has limitations though, especially for patients with renal and...

    Authors: Antoine Barocas, Philippe Savard, Audrey Carlo, Thomas Lecompte and Emmanuel de Maistre
    Citation: Thrombosis Journal 2023 21:100
    Content type: Research Published on:

  33. Although the atherogenic index of plasma (AIP) based on a single measurement is a known risk factor for cardiovascular disease (CVD), little is known about whether changes in AIP over time are related to incid...

    Authors: Dong-Wook Chun, Yae-Ji Lee, Jun-Hyuk Lee and Ji-Won Lee
    Citation: Thrombosis Journal 2023 21:99
    Content type: Research Published on:

  36. This study aimed to assess the outcomes of thrombectomy with/without iliac vein stenting for young and transiently provoked DVT patients with iliac vein stenosis.

    Authors: Hongji Pu, Jumin Song, Zhijun He, Fuyin Wang, Jiateng Hu, Sheng Huang, Minyi Yin, Weimin Li, Xiaobing Liu, Xinwu Lu and Guang Liu
    Citation: Thrombosis Journal 2023 21:96
    Content type: Research Published on:

  37. Venous thromboembolism(VTE) is a leading cause of death in patients with lung cancer. Furthermore, hospitalization of patients with advanced lung cancer for VTE treatment represents a major economic burden on ...

    Authors: Wenjuan Di, Haotian Xu, Chunhua Ling and Ting Xue
    Citation: Thrombosis Journal 2023 21:95
    Content type: Research Published on:

  38. Tranexamic acid (TXA) is a widely used antifibrinolytic agent that has been used since the 1960’s to reduce blood loss in various conditions. TXA is a lysine analogue that competes for the lysine binding sites...

    Authors: Tammy Lam, Robert L. Medcalf, Geoffrey C. Cloud, Paul S. Myles and Charithani B. Keragala
    Citation: Thrombosis Journal 2023 21:94
    Content type: Review Published on:

  40. The prevalence of anti-platelet factor 4 (PF4)/polyanionic antibodies occurring after vaccination with ChAdOx1 nCoV-19 is low. Most of these antibodies are not associated with vaccine-induced thrombotic thromb...

    Authors: Kochawan Boonyawat, Tichayapa Phojanasenee, Phichchapha Noikongdee, Pornnapa Police, Pichika Chantrathammachart, Pimjai Niparuck, Teeraya Puavilai, Angsana Phuphuakrat and Pantep Angchaisuksiri
    Citation: Thrombosis Journal 2023 21:92
    Content type: Research Published on:

  41. Upon cellular injury, damage-associated molecular patterns (DAMPs) are released into the extracellular space and evoke proinflammatory and prothrombotic responses in animal models of sterile inflammation. Howe...

    Authors: Kenshin Shimono, Takashi Ito, Chinatsu Kamikokuryo, Shuhei Niiyama, Shingo Yamada, Hirokazu Onishi, Hideaki Yoshihara, Ikuro Maruyama and Yasuyuki Kakihana
    Citation: Thrombosis Journal 2023 21:91
    Content type: Research Published on:

  44. An established treatment strategy for asymptomatic pulmonary embolism (PE) or deep vein thrombosis (DVT) remains uncertain in Japan; therefore, in this study, we clarify the characteristics and outcomes of sym...

    Authors: Shohei Migita, Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda, Takeshi Yamashita, Takanori Ikeda, Makoto Mo, Tsutomu Yamazaki and Atsushi Hirayama
    Citation: Thrombosis Journal 2023 21:88
    Content type: Research Published on:

  45. Takayasu’s arteritis (TAK) is a rare chronic granulomatous arteritis that mainly affects the aorta and its major branches. Coronary artery (CA) involvement can be observed in 10–25% of TAK patients. We report ...

    Authors: Shichu Liang, Jinming Yang, Min Ma, Minggang Zhou, Zhiyue Liu, He Huang and Yong He
    Citation: Thrombosis Journal 2023 21:87
    Content type: Case Report Published on:

  46. Despite the risks of venous thromboembolism (VTE) in surgical patients are well defined, primary thromboprophylaxis (TP) can be neglected. The aim of this study was to evaluate the risk of VTE and appropriaten...

    Authors: Zeynep Karaburç Kiracı, Nadir Yalçın, Ömer Cennet, Kutay Demirkan and Kaya Yorgancı
    Citation: Thrombosis Journal 2023 21:86
    Content type: Research Published on:

  47. Lavender oil (LO) possesses anti-inflammatory, antioxidant, antifungal, antibacterial, sedative, cardio-protective, and antinociceptive properties. Thrombosis and inflammation are interplayed processes that in...

    Authors: Valeriu Mihai But, Adriana Elena Bulboacă, Vasile Rus, Tamás Ilyés, Mădălina Luciana Gherman and Sorana D. Bolboacă
    Citation: Thrombosis Journal 2023 21:85
    Content type: Research Published on:

  48. We compared the prognostic value of the Japanese Society on Thrombosis and Hemostasis (JSTH) disseminated intravascular coagulation (DIC) diagnostic criteria with that of the International Society on Thrombosi...

    Authors: Hirotaka Mori, Kayo Harada-Shirado, Noriaki Kawano, Mineji Hayakawa, Yoshinobu Seki, Toshimasa Uchiyama, Kazuma Yamakawa, Hiroyasu Ishikura, Yuhei Irie, Kenji Nishio, Noritaka Yada, Kohji Okamoto and Takayuki Ikezoe
    Citation: Thrombosis Journal 2023 21:84
    Content type: Research Published on:

  49. Stroke prevention with oral anticoagulant (OAC) therapy, including non-vitamin K antagonist oral anticoagulants (NOACs), is recommended in patients with atrial fibrillation (AF). This analysis describes the an...

    Authors: Xiaoxia Liu, Guoze Feng, Sabrina Vogel Marler, Menno V Huisman, Gregory Y. H. Lip and Changsheng Ma
    Citation: Thrombosis Journal 2023 21:83
    Content type: Research Published on:

  50. Venous thromboembolism (VTE) is a common thrombotic vascular disease that has a significant impact on people’s well-being and quality of life. A plethora of clinical studies explore the relationship between in...

    Authors: Jiayue Ding, Xuanye Yue, Xiaobing Tian, Zhangyuan Liao, Ran Meng and Ming Zou
    Citation: Thrombosis Journal 2023 21:82
    Content type: Review Published on:
Submit manuscript

Official journal of

  • APSTH logo

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.011 - SNIP (Source Normalized Impact per Paper)
    0.699 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    107 days submission to accept (Median)

    2023 Usage 
    708,004 downloads
    943 Altmetric mentions 

Thrombosis Journal

ISSN: 1477-9560

Contact us